The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa

Andrew J. Prendergast; Alexander J. Szubert; Godfrey Pimundu; Chipo Berejena; Pietro Pala; Annie Shonhai; Patricia Hunter; Francesca I.F. Arrigoni; Victor Musiime; Mutsa Bwakura-Dangarembizi; Philippa Musoke; Hannah Poulsom; MacKlyn Kihembo; Paula Munderi; Diana M. Gibb; Moira J. Spyer; A. Sarah Walker; Nigel Klein

doi:10.1097/QAD.0000000000002916

The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa

Andrew J. Prendergast
, Alexander J. Szubert
, Godfrey Pimundu
, Chipo Berejena
, Pietro Pala
, Annie Shonhai
, Patricia Hunter
, Francesca I.F. Arrigoni
, Victor Musiime
, Mutsa Bwakura-Dangarembizi
, Philippa Musoke
, Hannah Poulsom
, MacKlyn Kihembo
, Paula Munderi
, Diana M. Gibb
, Moira J. Spyer
, A. Sarah Walker
, Nigel Klein

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1537-1548
Journal	AIDS
Volume	35
Issue number	10
Early online date	1 Aug 2021
DOIs	https://doi.org/10.1097/QAD.0000000000002916
Publication status	Published - 1 Aug 2021

Bibliographical note

Impact: This work was supported by the UK Medical Research Council (MRC) [G1001190]. The ARROW trial was jointly funded by the UK Medical Research Council (MRC) [G0300400] and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and was also part of the EDCTP2 programme supported by the European Union. This work was also supported by the UK Medical Research Council [MC_UU_12023/26]. A.J.P. is funded by the Wellcome Trust [108065/Z/15/Z]. Drugs were donated and viral load assays funded by ViiV Healthcare/GlaxoSmithKline

Keywords

Infection and immunology

Access to Document

10.1097/QAD.0000000000002916

https://doi.org/10.1097/QAD.0000000000002916

Cite this

Prendergast, A. J., Szubert, A. J., Pimundu, G., Berejena, C., Pala, P., Shonhai, A., Hunter, P., Arrigoni, F. I. F., Musiime, V., Bwakura-Dangarembizi, M., Musoke, P., Poulsom, H., Kihembo, M., Munderi, P., Gibb, D. M., Spyer, M. J., Walker, A. S., & Klein, N. (2021). The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa. AIDS, 35(10), 1537-1548. https://doi.org/10.1097/QAD.0000000000002916

@article{3942de0855384758a2687126b53f70c9,

title = "The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa",

keywords = "Infection and immunology",

author = "Prendergast, \{Andrew J.\} and Szubert, \{Alexander J.\} and Godfrey Pimundu and Chipo Berejena and Pietro Pala and Annie Shonhai and Patricia Hunter and Arrigoni, \{Francesca I.F.\} and Victor Musiime and Mutsa Bwakura-Dangarembizi and Philippa Musoke and Hannah Poulsom and MacKlyn Kihembo and Paula Munderi and Gibb, \{Diana M.\} and Spyer, \{Moira J.\} and Walker, \{A. Sarah\} and Nigel Klein",

note = "Impact: This work was supported by the UK Medical Research Council (MRC) [G1001190]. The ARROW trial was jointly funded by the UK Medical Research Council (MRC) [G0300400] and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and was also part of the EDCTP2 programme supported by the European Union. This work was also supported by the UK Medical Research Council [MC\_UU\_12023/26]. A.J.P. is funded by the Wellcome Trust [108065/Z/15/Z]. Drugs were donated and viral load assays funded by ViiV Healthcare/GlaxoSmithKline",

year = "2021",

month = aug,

day = "1",

doi = "10.1097/QAD.0000000000002916",

language = "English",

volume = "35",

pages = "1537--1548",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

Prendergast, AJ, Szubert, AJ, Pimundu, G, Berejena, C, Pala, P, Shonhai, A, Hunter, P, Arrigoni, FIF, Musiime, V, Bwakura-Dangarembizi, M, Musoke, P, Poulsom, H, Kihembo, M, Munderi, P, Gibb, DM, Spyer, MJ, Walker, AS & Klein, N 2021, 'The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa', AIDS, vol. 35, no. 10, pp. 1537-1548. https://doi.org/10.1097/QAD.0000000000002916

TY - JOUR

T1 - The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa

AU - Prendergast, Andrew J.

AU - Szubert, Alexander J.

AU - Pimundu, Godfrey

AU - Berejena, Chipo

AU - Pala, Pietro

AU - Shonhai, Annie

AU - Hunter, Patricia

AU - Arrigoni, Francesca I.F.

AU - Musiime, Victor

AU - Bwakura-Dangarembizi, Mutsa

AU - Musoke, Philippa

AU - Poulsom, Hannah

AU - Kihembo, MacKlyn

AU - Munderi, Paula

AU - Gibb, Diana M.

AU - Spyer, Moira J.

AU - Walker, A. Sarah

AU - Klein, Nigel

N1 - Impact: This work was supported by the UK Medical Research Council (MRC) [G1001190]. The ARROW trial was jointly funded by the UK Medical Research Council (MRC) [G0300400] and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and was also part of the EDCTP2 programme supported by the European Union. This work was also supported by the UK Medical Research Council [MC_UU_12023/26]. A.J.P. is funded by the Wellcome Trust [108065/Z/15/Z]. Drugs were donated and viral load assays funded by ViiV Healthcare/GlaxoSmithKline

PY - 2021/8/1

Y1 - 2021/8/1

KW - Infection and immunology

UR - https://shop.lww.com/AIDS/p/0269-9370

U2 - 10.1097/QAD.0000000000002916

DO - 10.1097/QAD.0000000000002916

M3 - Article

SN - 0269-9370

VL - 35

SP - 1537

EP - 1548

JO - AIDS

JF - AIDS

IS - 10

ER -

The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this